About the Post-Conference Planner
- In total 27 abstracts were relevant to the RNA module, 5 of which were late-breaking. 9 new RNA assets were identified from the abstracts presented at 2022 AACR.
- This report provides an analysis of the 27 abstracts, assessed by delivery system, therapeutic class, and disease indication, followed by top-level summaries of the preclinical and clinical abstracts presented.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements